Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × fluoroazomycin arabinoside × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hypoxia 4 Uterine Cervical Neoplasms 3 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Hypoxic Tumours 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Adenosquamous 1 Adenocarcinoma 1

Interventions

Doxorubicin 127 Ifosfamide 76 Radiotherapy 73 Cyclophosphamide 64 Gemcitabine 54 Filgrastim 48 pazopanib 38 pembrolizumab 36 Trabectedin 36 Etoposide 36 Docetaxel 35 Vincristine 34 Cisplatin 30 Nivolumab 29 Magnetic Resonance Spectroscopy 23 Irinotecan 23 Carboplatin 22 Temozolomide 20 Surgical Procedures, Operative 20 Radiation 20 Ipilimumab 20 Mesna 17 Granulocyte Colony-Stimulating Factor 17 Biopsy 17 Bevacizumab 17 Sirolimus 16 Melphalan 16 Blood Specimen Collection 16 eribulin 15 anlotinib 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03418818 2026-03-06

FAZA PET/MRI Sarcoma

University Health Network, Toronto

Phase NA Active not recruiting

Hypoxia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡